HBP-412

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHBP-412
Drug Alias Namesecond generation therapy (Hy BioPharma)HBP-412
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHy Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHy Biopharma
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A